Trial Profile

Effect of Dapagliflozin on left ventricular diastolic function in patients with type 2 diabetic patients with chronic heart failure

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dapagliflozin (Primary)
Indications Heart failure; Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

30 Mar 2020 Results presented at the 2020 Annual Scientific Session of the American College of Cardiology and World Congress of Cardiology
18 Mar 2019 Primary endpoint has been met.
18 Mar 2019 Results assessing Effect of Dapagliflozin on Left Ventricular Diastolic Function of Patients With Type 2 Diabetic Mellitus With Chronic Heart Failure presented at the 68th Annual Scientific Session of the American College of Cardiology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com